Le Lézard
Classified in: Health
Subjects: NPT, PLW, MAT

Peak Health and ImmunAg, LLP Announce Filing of Patent Applications for Humulus kriya- a Plant That Contains Non Psychotropic Cannabinoids


LOS GATOS, Calif., March 19, 2018 /PRNewswire/ -- Peak Health Center, a 501(c)(3), Not-For-Profit, Corporation, and ImmunAg, LLP, a Goa, India, private Corporation, announced that multiple patent applications have been filed for inventions relating to Humulus plants having high cannabidiol (CBD) levels in their leaves and inflorescence. These patent applications are also directed at the extracts of these Humulus plants, the compositions of these extracts, and the methods of treatment involving these compositions.

Humulus outgrowth

The Humulus kriya plant contains no Tetrahydrocannabinol (THC), nor any psychotropic cannabinoids. The extract from Humulus kriya also contains no THC or psychotropic cannabinoids. This is a significant advantage over extracts from cannabis or hemp, which have traces of THC which have to be removed or regulated.

The unique extract from Humulus kriya, rich in ?-Caryophyllene, Humulene and Cannabidiol has been Trademarked as ImmunAgtm. The Food and Safety Standards Authority of India has approved and licensed ImmunAgtm, as a "Food Ingredient", and permitted it's import, if needed. There are no restrictions for export out of India and ImmunAg, LLP has the required e-IEC Import Export Code to export ImmunAgtm.

ImmunAg LLP grows Humulus kriya and manufactures ImmunAgtm. Peak Health Center is the exclusive distributor of ImmunAgtm in USA.

"Mainstream food and pharmaceutical companies have not been able to use or conduct research with CBD from Cannabis or Hemp. They will now be able to use  ImmunAgtm  without the negative stigma of Cannabis. It is currently approved as a food ingredient. We are hoping to have it approved as a phyto pharmaceutical in the near future," said Mr. Ashutosh Kotru, Director, ImmunAg LLP.

"This is significant. Humulus will be known for more than beer. Cannabis no longer has a monopoly on CBD. Governments don't need to suppress it. People can use it without fear. And we can openly study its medical benefits," said Dr. Avi Cohen, Expert, Traditional Complementary and Integrative Medicine Group, World Health Organization, Geneva, Switzerland.

ImmunAgtm will be available for sale from April 1st, 2018 at www.immun.ag or by calling (844) 960-7325. It retails for $24,999 per kg.

Peak Health Center
Is a 501(c)(3), Not-For-Profit Corporation, based out of Los Gatos, CA. Its charter is to improve human health, with the least use of pharmaceutical drugs.  Its doctors from around the globe are volunteering efforts to enhance our knowledge of endogenous health and Phytotherapy.

ImmunAg LLP
Is a private Corporation, based out of Goa, India. It grows Humulus kriya, extracts ImmunAgtm from its pods, and conducts research on the efficacy of ImmunAgtm.

Press Contact
Name: Jessica Shavers
Phone: (415) 755-7422
Email: [email protected]

 

Humulus Pod

Peak Health Center Logo

SOURCE Peak Health Center


These press releases may also interest you

at 06:30
Boston Scientific Corporation generated net sales of $3.856 billion during the first quarter of 2024, growing 13.8 percent on a reported basis, 15.0 percent on an operational1 basis and 13.1 percent on an organic2 basis, all compared to the prior...

at 06:28
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Pharma Parenteral Packaging Market ? By Drug Type (Small Molecules, Biologics, Vaccines, Biosimilars, & Others), By Product Type (Bottles, Ampoules,...

at 06:15
Overall 8.46 Average Revised Venous Clinical Severity Score (rVCSS) Improvement Per Patient for Patients Showing Clinical Meaningful Benefit (rVCSS Improvement ≥ 3 Points) including:9.29 Points for Patients at the Two-Year Milestone8.08 Points...

at 06:10
Thermo Fisher Scientific Inc. , the world leader in serving science, will hold its 2024 Investor Day on Thursday, September 19, starting at 9:00 a.m. (ET) in New York City. The format will feature presentations by members of Thermo Fisher...

at 06:05
Thermo Fisher Scientific Inc. , the world leader in serving science, today reported its financial results for the first quarter ended March 30, 2024. First Quarter 2024 Highlights First quarter revenue was $10.34 billion. First quarter GAAP...

at 06:05
Biodesix, Inc. , a leading diagnostic solutions company with a focus in lung disease, announced today that it will release financial results for the first quarter ended March 31, 2024 after the close of trading on Wednesday, May 8. Biodesix's...



News published on and distributed by: